JP2020182486A5 - - Google Patents

Download PDF

Info

Publication number
JP2020182486A5
JP2020182486A5 JP2020123157A JP2020123157A JP2020182486A5 JP 2020182486 A5 JP2020182486 A5 JP 2020182486A5 JP 2020123157 A JP2020123157 A JP 2020123157A JP 2020123157 A JP2020123157 A JP 2020123157A JP 2020182486 A5 JP2020182486 A5 JP 2020182486A5
Authority
JP
Japan
Prior art keywords
antigen
conjugation
subject
cell
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020123157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020182486A (ja
JP7079819B2 (ja
Filing date
Publication date
Priority claimed from GB201415247A external-priority patent/GB201415247D0/en
Priority claimed from GB201420773A external-priority patent/GB201420773D0/en
Application filed filed Critical
Publication of JP2020182486A publication Critical patent/JP2020182486A/ja
Publication of JP2020182486A5 publication Critical patent/JP2020182486A5/ja
Application granted granted Critical
Publication of JP7079819B2 publication Critical patent/JP7079819B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020123157A 2014-08-28 2020-07-17 化合物および方法 Expired - Fee Related JP7079819B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB201415247A GB201415247D0 (en) 2014-08-28 2014-08-28 Compound and method
GB1415247.4 2014-08-28
GB1420773.2 2014-11-21
GB201420773A GB201420773D0 (en) 2014-11-21 2014-11-21 Compound and method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017511702A Division JP2017526371A (ja) 2014-08-28 2015-08-28 化合物および方法

Publications (3)

Publication Number Publication Date
JP2020182486A JP2020182486A (ja) 2020-11-12
JP2020182486A5 true JP2020182486A5 (https=) 2021-04-15
JP7079819B2 JP7079819B2 (ja) 2022-06-02

Family

ID=54065872

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017511702A Pending JP2017526371A (ja) 2014-08-28 2015-08-28 化合物および方法
JP2020123157A Expired - Fee Related JP7079819B2 (ja) 2014-08-28 2020-07-17 化合物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017511702A Pending JP2017526371A (ja) 2014-08-28 2015-08-28 化合物および方法

Country Status (9)

Country Link
US (1) US10537639B2 (https=)
EP (1) EP3185901B1 (https=)
JP (2) JP2017526371A (https=)
KR (1) KR102678732B1 (https=)
CN (1) CN108136016A (https=)
AU (1) AU2015308345B9 (https=)
BR (1) BR112017003486A2 (https=)
NZ (1) NZ729408A (https=)
WO (1) WO2016030529A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912607B (zh) * 2018-12-11 2021-01-22 南华大学 一类卟啉-白杨素复合物及其抗肿瘤活性
JP7288951B2 (ja) 2019-02-19 2023-06-08 大塚電子株式会社 光線力学的療法条件パラメータの決定方法および光線力学的療法装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
KR100980153B1 (ko) 2000-11-29 2010-09-03 피씨아이 바이오테크 에이에스 사이토졸 내로의 분자 전달을 위한 광화학적 내부이행
AU2002230693B2 (en) 2000-12-13 2006-08-17 Immunex Corporation Method for generating immortal dendritic cell lines
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
ES2623812T3 (es) * 2003-11-12 2017-07-12 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Vectores a medida para tratar y prevenir cáncer pancreático
WO2005097976A1 (ja) * 2004-04-06 2005-10-20 Ehime University 抗原パルスして得られた樹状細胞
WO2005100547A1 (ja) * 2004-04-06 2005-10-27 Techno Network Shikoku Co., Ltd. 抗原パルスして得られた樹状細胞
EP2307047A4 (en) * 2008-06-06 2011-09-07 Baylor Res Inst RESPIRATORY SYNCYTIAL VIRUS MAKES TOLEROGENIC DENDRITIC CELLS
US20120269765A1 (en) 2009-07-24 2012-10-25 Garcia K Christopher Cytokine compositions and methods of use thereof
GB201208548D0 (en) * 2012-05-15 2012-06-27 Pci Biotech As Compound and method
CA2906279A1 (en) * 2013-03-15 2014-09-18 Pci Biotech As A method of generating antigen presenting cells using photochemical internalisation
JP6684215B2 (ja) * 2013-08-28 2020-04-22 ピーシーアイ バイオテック エイエス 予防接種用化合物および免疫化用化合物、ならびに予防接種方法および免疫化方法
WO2015028575A1 (en) * 2013-08-28 2015-03-05 Pci Biotech As Immunisation method by photochemical internalisation
AU2014390262B2 (en) * 2014-04-11 2020-11-26 Pci Biotech As Method of treating melanoma

Similar Documents

Publication Publication Date Title
Kreutz et al. Targeting dendritic cells—why bother?
ES2350043T3 (es) Composiciones para producir, incrementar y mantener las respuestas inmunes contra epítopos restringidos de mhc de clase i, con fines profilácticos o terapéuticos.
US20260077049A1 (en) Compounds including a mutant kras sequence and a lipid and uses thereof
CA3016457A1 (en) Sting activating nanovaccine for immunotherapy
TW200307557A (en) Stabilized synthetic immunogen delivery systems
RU2014150569A (ru) Конъюгат фотосенсибилизатора и хитозана и его применение
TWI861015B (zh) 包含抗原肽-佐劑核苷酸結合物之免疫誘導劑及包含其之醫藥組成物
US8834899B2 (en) Photodynamic therapy-generated mesothelioma vaccine
Chen et al. Maximizing TLR9 activation in cancer immunotherapy with dual-adjuvanted spherical nucleic acids
JP2020182486A5 (https=)
Lee et al. Biodegradable cationic polycarbonates as vaccine adjuvants
JP2006502228A5 (https=)
CN103961697A (zh) 粘膜给予用疫苗组合物
Ou et al. Transcutaneous Immunization of 1D Rod-Like Tobacco-Mosaic-Virus-Based Peptide Vaccine via Tip-Loaded Dissolving Microneedles
BRPI0618847A2 (pt) novos adjuvantes com base em conjugados de bisaciloxipropilcisteìna e derivados e seus usos em composições farmacêuticas
US11464798B2 (en) Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same
JPH07504662A (ja) 免疫無防備状態の宿主における治療用途のための免疫促進剤
EP1237573B1 (fr) Utilisation de proteines immunogenes immunosuppressives ou angiogeniques rendues inactives pour la production d'lga secretoires
RU2404794C2 (ru) Вагинальные суппозитории для лечения рака шейки матки
JPWO2020217226A5 (https=)
RU2379055C1 (ru) Способ лечения онкологических заболеваний
Mahmud et al. Challenges, Approaches & Applications of Orotransmucosal Drug Delivery System
KR102956061B1 (ko) 항원 펩티드-아쥬반트 뉴클레오티드 컨쥬게이트체를 포함하는 면역 유도제 및 그것을 포함하는 의약 조성물
ES2280948T3 (es) Composiciones de vacunas basadas en gangliosidos para administracion por via subcutanea.
RU2013139439A (ru) Олигопептиды металлопротеиназ и их терапевтическое применение